RETHINK REFLUX レジストリ
逆流性疾患に対する LINX の役割についての考察をさらに深めるための研究
The RETHINK REFLUX Registry is a post-market prospective, multi-center, observation, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant) up to 10 years post-implant.
調査の概要
詳細な説明
The RETHINK REFLUX Registry or Research to further inform thinking about the role of LINX for Reflux Disease is sponsored by Ethicon Endo-Surgery, Inc. This is a post-market prospective, multi-center, observational, single arm, long-term safety surveillance registry of subjects implanted with the LINX device. Up to 500 subjects will be enrolled and implanted at up to 50 centers in both the US and selected countries outside the US with regulatory approval for the LINX Reflux Management System. The study will collect data from patients 10 years post implant. The primary objective of the study is to confirm the long-term safety profile of the LINX device and procedure (implant/explant). Secondary objectives include Effectiveness, Health Economics and Health Utilization.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Alabama
-
Mobile、Alabama、アメリカ、36617
- University of South Alabama
-
-
Arizona
-
Tucson、Arizona、アメリカ、85741
- NW Allied Bariatric and Foregut Surgery
-
-
California
-
Los Angeles、California、アメリカ、90033
- Keck Hospital of USC
-
-
Colorado
-
Englewood、Colorado、アメリカ、80113
- Institute of Esophageal and Reflux Surgery
-
-
Florida
-
Tampa、Florida、アメリカ、33606
- University of Southern Florida (Tampa General Hospital)
-
-
Illinois
-
Peoria、Illinois、アメリカ、61615
- OSF Medical Group
-
-
Kentucky
-
Edgewood、Kentucky、アメリカ、41017
- Saint Elizabeth Healthcare Edgewood
-
-
Michigan
-
Lansing、Michigan、アメリカ、48912
- Sparrow Hospital / Sparrow Medical Group
-
-
North Carolina
-
Greenville、North Carolina、アメリカ、27834
- East Carolina University / Vidant Medical Center
-
-
Ohio
-
Columbus、Ohio、アメリカ、43210
- The Ohio State University
-
Lancaster、Ohio、アメリカ、43130
- Gen Surg Assoc / Fairfield Medical Center
-
-
Pennsylvania
-
Allentown、Pennsylvania、アメリカ、18102
- Lehigh Valley Hospital - Cedar Crest
-
-
South Carolina
-
Greenville、South Carolina、アメリカ、29607
- Minimal Access Surgery/Prisma Health - Upstate
-
Greenwood、South Carolina、アメリカ、29646
- Adv Surg Assoc / Self Regional Healthcare
-
West Columbia、South Carolina、アメリカ、29169
- Lexington Surgery
-
-
Texas
-
Amarillo、Texas、アメリカ、79106
- Panhandle Weight Loss Center
-
Houston、Texas、アメリカ、77030
- Houston Methodist
-
San Antonio、Texas、アメリカ、78258
- Bariatric Medical Institute of Texas
-
-
Virginia
-
Richmond、Virginia、アメリカ、23229
- Richmond Surg / Henrico Doctors' Hospital
-
-
Washington
-
Seattle、Washington、アメリカ、98104
- Swedish Medical Center
-
-
Wisconsin
-
Appleton、Wisconsin、アメリカ、54911
- Fox Valley Surgical Associates
-
-
-
-
-
Epsom、イギリス、KT18 7EG
- Epsom Hospital
-
London、イギリス、SE1 7EH
- Guy's and St. Thomas' Hospitals
-
Royal Tunbridge Wells、イギリス、TN3 0RD
- RefluxUK
-
-
-
-
-
San Donato Milanese、イタリア、20097
- Univ of Milano / IRCCS Policlinico San Donato
-
-
-
-
-
Vienna、オーストリア、1090
- MedUni Wien / Universitatsklinik fur Chirurgie
-
-
-
-
-
Singapore、シンガポール、119228
- National University Hospital
-
-
-
-
-
Herne、ドイツ、44625
- Marien Hospital Herne
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Adult patients successfully implanted (treated) with the LINX Reflux Management System for the treatment of GERD (Implant success defined as leaving the surgical suite with a device in situ)
説明
Inclusion Criteria:
- Subject is >or=21 years old
- Subject with prospective plans for a LINX procedure
- Subject provides written informed consent
- Subject must be willing and able to complete questionnaires/ surveys electronically (ePROs)
Exclusion Criteria:
- Subject who was previously implanted with LINX device
- Any reason which the Principal Investigator believes may cause the subject to be non-compliant with or unable to meet the protocol requirements (i.e. medical illness and/or limited life expectancy of less than 10 years)
Note: Physicians should refer to the LINX Reflux Management System IFU for a complete list of contraindications, warnings, and precautions.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:CASE_ONLY
- 時間の展望:PROSPECTIVE
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Safety - Adverse Events
時間枠:10 years
|
Adverse events related to the LINX device and/or procedure (implant/explant) limited to:
|
10 years
|
|
Safety - Explant/Removal
時間枠:10 years
|
LINX explant/removal |
10 years
|
|
Safety - Hiatal Hernia Reoccurrence
時間枠:10 years
|
Hiatal hernia requiring repair (occurring after the LINX implant) |
10 years
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Effectiveness
時間枠:10 years
|
Follow-up questionnaires Gastroesophageal Reflux Disease Esophageal Health Related Quality of Life Questionnaire (GERD-HRQL), Foregut Symptoms Questionnaire (FSQ) and GERD Medication Survey] will be collected and compared to baseline with evaluation to include:
|
10 years
|
|
Health Economics - Work Productivity and Activity Impairment
時間枠:10 years
|
Measure of the impact of GERD on a subject's ability to work will be collected through the responses on the Work Productivity and Activity Impairment (WPAI) questionnaire. Percentages of impairment at baseline will be compared to scores collected annually. Four types of scores will be analyzed:
|
10 years
|
|
Health Economics - GERD Treatment Decision-Making Process (Subject's Perspective)
時間枠:Baseline
|
To better understand a subject's process for making GERD related healthcare decisions and his/her care pathways, the LINX Interest Survey will be collected once at baseline, prior the implant procedure |
Baseline
|
|
Health Economics - Healthcare Utilization
時間枠:10 years
|
Analysis of healthcare economics in subjects who seek treatment for worsening of GERD symptoms and device/procedural complications over 10 years. A Healthcare Encounter Survey will be completed by subjects. |
10 years
|
協力者と研究者
スポンサー
捜査官
- スタディディレクター:Jeffery Lowell, MD、Ethicon Endo-Surgery
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- TRX_2018_01
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD プランの説明
Johnson & Johnson Medical Device Companies have an agreement with the Yale Open Data Access (YODA) Project to serve as the independent review panel for evaluation of requests for clinical study reports and participant level data from investigators and physicians for scientific research that will advance medical knowledge and public health. Requests for access to the study data can be submitted through the YODA Project site at http://yoda.yale.edu.
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
米国で製造され、米国から輸出された製品。
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。